BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 22541695)

  • 21. Primary biliary cirrhosis and primary sclerosing cholangitis.
    Angulo P; Lindor KD
    Clin Liver Dis; 1999 Aug; 3(3):529-70. PubMed ID: 11291238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recognizing primary biliary cirrhosis and primary sclerosing cholangitis.
    Buckley SE; DiPalma JA
    Am Fam Physician; 1996 Jan; 53(1):195-200. PubMed ID: 8546046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble intercellular adhesion molecule-1 in primary biliary cirrhosis: relationship with disease stage, immune activity and cholestasis.
    Lim AG; Jazrawi RP; Ahmed HA; Levy JH; Zuin M; Douds AC; Maxwell JD; Northfield TC
    Hepatology; 1994 Oct; 20(4 Pt 1):882-8. PubMed ID: 7927229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Inflammatory diseases of the gall bladder and biliary system. II. Acute and chronic inflammation of the biliary system--primary biliary cirrhosis].
    Helmberger H; Kammer B
    Radiologe; 2005 Jun; 45(6):569-78; quiz 579. PubMed ID: 15947974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parenteral nutrition dysregulates bile salt homeostasis in a rat model of parenteral nutrition-associated liver disease.
    Koelfat KVK; Schaap FG; Hodin CMJM; Visschers RGJ; Svavarsson BI; Lenicek M; Shiri-Sverdlov R; Lenaerts K; Olde Damink SWM
    Clin Nutr; 2017 Oct; 36(5):1403-1410. PubMed ID: 28029505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overlap syndromes of autoimmune hepatitis: diagnosis and treatment.
    Aguilar-Nájera O; Velasco-Zamora JA; Torre A
    Rev Gastroenterol Mex; 2015; 80(2):150-9. PubMed ID: 26091564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Occurrence of an abnormal lipoprotein in patients with liver disease.
    Ross A; Murphy GM; Wilkinson PA; Mills GL; Sherlock S
    Gut; 1970 Dec; 11(12):1035-7. PubMed ID: 5511783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Primary sclerosing cholangitis].
    Benhamou JP
    Rev Prat; 2000 Dec; 50(19):2146-9. PubMed ID: 11213459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: a pilot study.
    Trottier J; Białek A; Caron P; Straka RJ; Heathcote J; Milkiewicz P; Barbier O
    Dig Liver Dis; 2012 Apr; 44(4):303-10. PubMed ID: 22169272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced biliary excretion of canalicular membrane enzymes in estrogen-induced and obstructive cholestasis, and effects of different bile acids in the isolated perfused rat liver.
    Accatino L; Figueroa C; Pizarro M; Solís N
    J Hepatol; 1995 Jun; 22(6):658-70. PubMed ID: 7560859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Sarcoidosis and the liver].
    Ganne-Carrié N; Guettier C; Ziol M; Beaugrand M; Trinchet JC
    Ann Med Interne (Paris); 2001 Mar; 152(2):103-7. PubMed ID: 11357046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoimmune diseases of the liver.
    Manns MP
    Clin Lab Med; 1992 Mar; 12(1):25-40. PubMed ID: 1563239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spectacular elevations of serum alkaline phosphatase: clinical and pathological correlation.
    Patton RB
    Henry Ford Hosp Med J; 1970; 18(3):211-4. PubMed ID: 5456488
    [No Abstract]   [Full Text] [Related]  

  • 34. Contributing factors and outcomes of burn-associated cholestasis.
    de Tymowski C; Dépret F; Soussi S; Nabila M; Vauchel T; Chaussard M; Benyamina M; Ferry A; Cupaciu A; Jully M; Oueslati H; Fratani A; Coutrot M; Sogni P; Mimoun M; Chaouat M; Zagdanski AM; De Kerviler E; Mebazaa A; Moreau R; Mallet V; Legrand M;
    J Hepatol; 2019 Sep; 71(3):563-572. PubMed ID: 31152758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The epidemiology of cholestasis in hepatopathies].
    Budillon G
    Ann Ital Med Int; 1993 Oct; 8 Suppl():36S-40S. PubMed ID: 7906951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chronic cholestatic disorders in the adult].
    Chazouillères O
    Pathol Biol (Paris); 1999 Nov; 47(9):974-82. PubMed ID: 10609278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic secretion enzymes and electrophoretic lipoprotein fractions in liver disease.
    Tăpălagă D; Opincaru A; Cucuianu M
    Acta Hepatogastroenterol (Stuttg); 1979 Feb; 26(1):9-16. PubMed ID: 34311
    [No Abstract]   [Full Text] [Related]  

  • 38. Manganese and copper levels in patients with primary biliary cirrhosis and primary sclerosing cholangitis.
    Dastych M; Husová L; Aiglová K; Fejfar T; Dastych M
    Scand J Clin Lab Invest; 2021 Apr; 81(2):116-120. PubMed ID: 33428478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Steinert's disease and cholestasis].
    Iglesias Arrabal M; Macías Rodríguez MA; Díaz García F; Martín Herrera L
    Med Clin (Barc); 1991 Oct; 97(12):475. PubMed ID: 1684406
    [No Abstract]   [Full Text] [Related]  

  • 40. High fat diet and liver damage induced by biliary obstruction in the rat.
    Muriel P
    J Appl Toxicol; 1995; 15(2):125-8. PubMed ID: 7782557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.